Search Results

Filter
  • 1-10 of  241 results for ""INTERFERON alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Extended duration therapy regimens based on Pegylated interferon for chronic hepatitis B patients focusing on hepatitis B surface antigen loss: A systematic review and meta-analysis.

  • Authors : Ma Y; International Medical Department, Beijing You-an Hospital, Capital Medical University, Beijing, China.; Wang J

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis B e Antigens/Hepatitis B e Antigens/Hepatitis B e Antigens/*drug effects ; Hepatitis B virus/Hepatitis B virus/Hepatitis B virus/*drug effects

  • Source: Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Infect Genet Evol] 2020 Nov; Vol. 85, pp. 104492. Date of Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 101084138 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

  • Authors : Piccinino F; Istituto di Malattie Infettive, II Università di Napoli, Italy.; Felaco FM

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepacivirus/Hepacivirus/Hepacivirus/*drug effects ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

  • Source: Research in virology [Res Virol] 1998 Sep-Oct; Vol. 149 (5), pp. 283-91.Publisher: Elsevier Country of Publication: France NLM ID: 8907469 Publication Model: Print Cited Medium: Print ISSN: 0923-2516 (Print)

Record details

×
Academic Journal

Absence of mutations in the human interferon alpha-2b gene in workers chronically exposed to ionising radiation.

  • Authors : Botbayev D; Aitkhozhin Institute of Molecular Biology and Biochemistry KS MES, Almaty, Kazakhstan.; Al-Farabi Kazakh National University, Almaty, Kazakhstan.

Subjects: Coal Mining* ; Radiation, Ionizing*; Environmental Biomarkers/Environmental Biomarkers/Environmental Biomarkers/*genetics

  • Source: Arhiv za higijenu rada i toksikologiju [Arh Hig Rada Toksikol] 2019 Jun 01; Vol. 70 (2), pp. 104-108.Publisher: Institut za medicinska istraz̆ivanja i medicinu rada Country of Publication: Croatia NLM ID: 0373100 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

[Interferon-alpha. Results of a pharmaco-epidemiologic study].

  • Authors : Grion AM; Dipartimento di Farmacologie dell'Università, Centro Regionale per la Documentazione e l'Informazione sul Farmaco, Padova.; Gaion RM

Subjects: Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use; Dose-Response Relationship, Drug ; Drug Evaluation

  • Source: La Clinica terapeutica [Clin Ter] 1994 Mar; Vol. 144 (3), pp. 201-11.Publisher: Societa Editrice Universo Country of Publication: Italy NLM ID: 0372604 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Antiviral treatment with pegylated interferon and clinical outcomes in a cohort of immigrants patients affected by hepatitis delta: A retrospective analysis.

  • Authors : Boglione L; Unit of Infectious Diseases, Department of Medical Sciences, Amedeo di Savoia Hospital, University of Turin, Turin, Italy.; Lupia T

Subjects: Emigrants and Immigrants*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis D, Chronic/Hepatitis D, Chronic/Hepatitis D, Chronic/*drug therapy

  • Source: Journal of medical virology [J Med Virol] 2019 Jul; Vol. 91 (7), pp. 1329-1334. Date of Electronic Publication: 2019 Mar 04.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects.

  • Authors : Carella C; Department of Clinical and Experimental Medicine F. Magrassi and A. Lanzara, Second University of Naples, 80121 Naples, Italy.; Mazziotti G

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*adverse effects ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*adverse effects ; Thyroid Diseases/Thyroid Diseases/Thyroid Diseases/*chemically induced

  • Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2004 Aug; Vol. 89 (8), pp. 3656-61.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Subjects: Cost-Benefit Analysis*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

  • Source: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver [Dig Liver Dis] 2014 Oct; Vol. 46 (10), Publisher: Elsevier Country of Publication: Netherlands NLM ID: 100958385 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Treatment Outcomes and Predictors of Response in Treatment-Naive HCV Patients Treated with Peginterferon Alfa/Ribavirin in Real-World Italian Clinics: Sub-Analysis from the PROPHESYS Cohort.

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis C/Hepatitis C/Hepatitis C/*drug therapy ; Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use

  • Source: Hepato-gastroenterology [Hepatogastroenterology] 2014 Jun; Vol. 61 (132), pp. 1094-106.Publisher: Thieme Country of Publication: Greece NLM ID: 8007849 Publication Model: Print Cited Medium: Print ISSN: 0172-6390 (Print) Linking

Record details

×
Academic Journal

Combination therapy with interferon-alpha plus N-acetyl cysteine for chronic hepatitis C: a placebo controlled double-blind multicentre study.

  • Authors : Grant PR; Department of Virology, Royal Free and University College Medical School, London, United Kingdom.; Black A

Subjects: Acetylcysteine/Acetylcysteine/Acetylcysteine/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

  • Source: Journal of medical virology [J Med Virol] 2000 Aug; Vol. 61 (4), pp. 439-42.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Print ISSN: 0146-6615 (Print)

Record details

×
Academic Journal

Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.

  • Authors : Betterle C; Department of Medical and Surgical Sciences, University of Padua, Italy. ; Fabris P

Subjects: Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use ; Autoantibodies/Autoantibodies/Autoantibodies/*blood ; Hepatitis C, Chronic/Hepatitis C, Chronic/Hepatitis C, Chronic/*drug therapy

  • Source: Diabetes care [Diabetes Care] 2000 Aug; Vol. 23 (8), pp. 1177-81.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
  • 1-10 of  241 results for ""INTERFERON alpha""